Photo from Erman Akkus/X
May 6, 2024, 19:10
Erman Akkus: ASCO Ed book on mNSCLC without oncogenic alterations
Erman Akkus, medical oncologist at Ankara Medical University, shared on Twitter/X:
“Metastatic NSCLC without oncogenic alterations
ASCO Educational Book
ICI as Monotherapy
ICI as Combination Treatment
ICI-ICI Combination Treatments
Clinical Decision Questions:
Best Approach in PD-L1≥50%
Role for Dual Checkpoint Blockade
Discontinuation Strategies in Long-term Responders to ICI
Second-Line Treatments
Future Approaches
Antibody-drug Conjugates
Chemotherapy-free First-Line Treatments.”
Visit the article website.
Source: Erman Akkus/X
Antibody drug conjugates
ASCO
cancer
cancer treatment
Check point Inhibitors
chemotherapy
Clinical Decision Making
combination therapy
Erman Akkus
immunotherapy
Long Term Responders
Lung cancer
medical oncology
monotherapy
NSCLC
OncoDaily
oncogenic alterations
Oncology
PD-L1
Treatment Strategies
AMP
May 19, 2024, 04:38